Answers are grounded in this paper and cite their sources.
Background: With the rising prevalence of health care as well as community-associated methicillin-resistant Staphylococcus aureus (MRSA) infections, and its clinical burden, evaluating the cost associated with its treatment will facilitate the efforts to optimise the implementation of effective preventive and curative interventions against the same. Patients and Methods: This was a prospective observational study at a 1500-bed tertiary care teaching hospital in India. Patients diagnosed with MRSA-skin and soft-tissue infections (SSTI) were screened. A purposive sampling method was used, covering the period from July 2021 to February 2022. Demographic and clinical data were collected from patient records. Cost analysis was conducted from a societal perspective, incorporating direct and indirect costs. Data were summarised using descriptive statistics. Results: A total of 60 patients were found to have MRSA-induced SSTI during the study period with the duration from admission to isolation being 7.16 ± 8.01 days. Overall, MRSA-induced SSTI resulted in a total of 572 additional days of hospitalisation after the isolation and a total expenditure of 2,922,061 INR (38,186.89 USD, 1 USD = 76.52 INR). The average days of antimicrobial therapy (DOT) after isolation were 14.01 ± 11.40 days with an average number of targeted AMAs prescribed was 1.50 ± 0.69. Conclusion: MRSA infections result in significant utilisation of healthcare resources. Effective implementation of preventive strategies may not only be economically beneficial but also can reduce the unnecessary burden on the healthcare resources and utilisation of high-end antimicrobials.
No takes yet. Share an insight, caveat, or question.
Thakkar et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: